GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PTC Therapeutics Inc (FRA:BH3) » Definitions » Float Percentage Of Total Shares Outstanding

PTC Therapeutics (FRA:BH3) Float Percentage Of Total Shares Outstanding : 74.21% (As of Apr. 29, 2024)


View and export this data going back to 2013. Start your Free Trial

What is PTC Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, PTC Therapeutics's float shares is 56.85 Mil. PTC Therapeutics's total shares outstanding is 76.61 Mil. PTC Therapeutics's float percentage of total shares outstanding is 74.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, PTC Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, PTC Therapeutics's Institutional Ownership is 57.85%.

PTC Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

PTC Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=56.85/76.61
=74.21%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PTC Therapeutics (FRA:BH3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PTC Therapeutics Inc (FRA:BH3) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
SWTX VCYT SMMT PNT RYTM BEAM CPRX IDYA VCEL HRMY OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PTCT:USA BH3:Germany
Address
100 Corporate Court, South Plainfield, NJ, USA, 07080
Website
https://www.ptcbio.com
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

PTC Therapeutics (FRA:BH3) Headlines

No Headlines